SCHEMBL30895660

SCHEMBL30895660

CC(C)(C)OC(=O)N1Cc2ccc(CCl)cc2C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.53
HDAC1 Q13547 1/20 0.53
NR1H2 P55055 2/20 0.52
DDB1 Q16531 1/20 0.49
CRBN Q96SW2 1/20 0.49
NAMPT P43490 5/20 0.45
MAPK1 P28482 1/20 0.43
PIK3CA P42336 1/20 0.41
MTOR P42345 1/20 0.41
ABHD6 Q9BV23 3/20 0.40
MGLL Q99685 1/20 0.40
ROCK2 O75116 1/20 0.40
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
DRD1 P21728 1/20 0.39
HRH2 P25021 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26131083 1.00 ESR2 (0.53) ESR2HDAC1NR1H2DDB1CRBN
SCHEMBL22981583 0.90 NR1H2 (0.67) ESR2HDAC1NR1H2DDB1CRBN
SCHEMBL29388691 0.90 NR1H2 (0.67) ESR2HDAC1NR1H2DDB1CRBN
SCHEMBL29974005 0.87 ESR2 (0.54) ESR2HDAC1NR1H2DDB1CRBN
SCHEMBL1650190 0.87 ESR2 (0.54) ESR2HDAC1NR1H2DDB1CRBN
SCHEMBL8921662 0.86 NR1H2 (0.55) ESR2HDAC1NR1H2DDB1CRBN
SCHEMBL18379840 0.86 ESR2 (0.53) ESR2HDAC1NR1H2DDB1CRBN
SCHEMBL30368320 0.86 ESR2 (0.53) ESR2HDAC1NR1H2DDB1CRBN
SCHEMBL18883051 0.86 ESR2 (0.53) ESR2HDAC1NR1H2DDB1CRBN
SCHEMBL29868910 0.86 NR1H2 (0.55) ESR2HDAC1NR1H2DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116615417-B 1, 4-Diheterocyclic group substituted aromatic ring or aromatic heterocyclic compound and application thereof 广州必贝特医药股份有限公司 2024-05-14 CN disclosed